v1
Real-world application of disitamab vedotin (RC48-ADC) in patients with breast cancer with different HER2 expression levels: efficacy and safety analysis.
Identifier:nobleid.org/w1/20260515/B7769DF6
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/B7769DF6)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims